We are live on ! Find out more
ACPU

Arrowgrass Capital Partners (US) Portfolio holdings

AUM $380M
1-Year Est. Return 20.87%
This Fund
S&P 500
This Quarter Est. Return
+6.22%
1 Year Est. Return
+20.87%
3 Year Est. Return
+55.83%
5 Year Est. Return
+146.17%
10 Year Est. Return
AUM
$6.72B
AUM Growth
+$218M
Cap. Flow
-$93.6M
Cap. Flow %
-1.39%
Top 10 Hldgs %
33.94%
Holding
621
New
215
Increased
156
Reduced
66
Closed
119

Sector Composition

Rank Sector Weight
1 Technology 9.95%
2 Healthcare 7.23%
3 Communication Services 5.88%
4 Industrials 3.21%
5 Energy 2.62%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PGND
126
DELISTED
PRESS GANEY HOLDINGS INC COM STK (DE)
PGND
$10.2M 0.15%
+356,227
New +$9.69M
HAL icon
127
CALL
Halliburton
HAL
$27B
$10.2M 0.15%
2,368
+1,288
+119% +$59.3K
VRTX icon
128
Vertex Pharmaceuticals
VRTX
$121B
$10.1M 0.15%
82,000
+54,500
+198% +$6.87M
MCK icon
129
McKesson
MCK
$100B
$10.1M 0.15%
45,000
+30,000
+200% +$6.94M
V icon
130
PUT
Visa
V
$683B
$9.96M 0.15%
1,484
+1,028
+225% +$69.7K
PFE icon
131
Pfizer
PFE
$143B
$9.92M 0.15%
+311,846
New +$10.2M
HD icon
132
CALL
Home Depot
HD
$332B
$9.58M 0.14%
+862
New +$96.5K
BRCD
133
DELISTED
Brocade Communications Systems, Inc. NEW
BRCD
$9.3M 0.14%
+783,064
New +$9.5M
WEN icon
134
Wendy's
WEN
$1.4B
$9.23M 0.14%
+817,925
New +$9.01M
USB icon
135
CALL
US Bancorp
USB
$98B
$9.19M 0.14%
2,118
+433
+26% +$18.9K
WMT icon
136
PUT
Walmart Inc
WMT
$888B
$9.12M 0.14%
3,855
+1,932
+100% +$49.3K
BIIB icon
137
Biogen
BIIB
$30.4B
$9.09M 0.14%
+22,500
New +$9.03M
PFE icon
138
CALL
Pfizer
PFE
$143B
$8.84M 0.13%
2,778
+1,722
+163% +$56.1K
ADAP
139
DELISTED
Adaptimmune Therapeutics
ADAP
$8.78M 0.13%
+478,854
New +$8.22M
TRTL
140
DELISTED
Terrapin 3 Acquisition Corporation Class A
TRTL
$8.78M 0.13%
864,500
+10,500
+1% +$105K
MET icon
141
CALL
MetLife
MET
$62.1B
$8.75M 0.13%
1,753
+1,018
+139% +$48.2K
TWTR
142
DELISTED
Twitter, Inc.
TWTR
$8.59M 0.13%
237,258
-184,742
-44% -$7.55M
RTX icon
143
PUT
RTX Corp
RTX
$290B
$8.59M 0.13%
+1,230
New +$90.2K
PFE icon
144
PUT
Pfizer
PFE
$143B
$8.49M 0.13%
+2,668
New +$87K
BIIB icon
145
CALL
Biogen
BIIB
$30.4B
$8.48M 0.13%
210
+99
+89% +$39.7K
PNC icon
146
PUT
PNC Financial Services
PNC
$99.8B
$8.47M 0.13%
886
+825
+1,352% +$78K
FOLD
147
DELISTED
Amicus Therapeutics
FOLD
$8.46M 0.13%
+598,064
New +$7.19M
MU icon
148
PUT
Micron Technology
MU
$945B
$8.4M 0.12%
+4,457
New +$119K
DIS icon
149
Walt Disney
DIS
$167B
$8.39M 0.12%
73,538
-58,962
-44% -$6.47M
MXIM
150
CALL
DELISTED
Maxim Integrated Products
MXIM
$8.09M 0.12%
+2,339
New +$80K

Similar funds

Arrowgrass Capital Partners (US)'s Q2 2015 Portfolio in Review

As of Q2 2015, Arrowgrass Capital Partners (US) held 621 positions worth $6.72B, up 3.4% from $6.51B the previous quarter. Its ten largest holdings account for 34% of the portfolio.

Arrowgrass Capital Partners (US)'s Q2 2015 filing shows 215 new, 156 increased, 66 reduced and 119 closed positions. Its largest new stake was CATAMARAN CORP COM STK (CDA): 2,091,156 shares worth $128M. The largest sale was RIVERBED TECHNOLOGY, INC COM, an estimated $171M.

By sector, the portfolio is most concentrated in Technology at 9.9% of assets, down from 11% a quarter earlier, followed by Healthcare and Communication Services.

  • Arrowgrass Capital Partners (US)'s largest Q2 2015 buy was CATAMARAN CORP COM STK (CDA): 2,091,156 shares worth $128M.
  • Arrowgrass Capital Partners (US) added most to BROADCOM CORP CL-A in Q2 2015, an estimated $117M increase.
  • Arrowgrass Capital Partners (US)'s biggest Q2 2015 reduction was DIRECTV COM STK (DE), cutting an estimated $137M.
  • Arrowgrass Capital Partners (US) fully exited RIVERBED TECHNOLOGY, INC COM in Q2 2015, selling an estimated $171M.
  • Arrowgrass Capital Partners (US)'s ten largest holdings make up 34% of its $6.72B portfolio in Q2 2015.
  • Arrowgrass Capital Partners (US) opened 215 new positions and closed 119 in Q2 2015.
  • Arrowgrass Capital Partners (US)'s portfolio value rose 3.4% quarter-over-quarter to $6.72B.

Based on Arrowgrass Capital Partners (US)'s 13F filing for Q2 2015, filed 14 Aug 2015.